The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists Reply

被引：0
|
作者：
Friedland, Sayuri [1 ]
Filion, Kristian B. [1 ,2 ]
Eisenberg, Mark J. [1 ,3 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada
[3] McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada
来源：
AMERICAN JOURNAL OF MEDICINE | 2013年 / 126卷 / 03期
关键词：
RISK;
D O I：
10.1016/j.amjmed.2012.10.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E13 / E13
页数：1
相关论文
共 50 条
  • [31] Pharmacophore Identification for Peroxisome Proliferator-Activated Receptor Gamma Agonists
    Sohn, Young-sik
    Lee, Yuno
    Park, Chanin
    Hwang, Swan
    Kim, Songmi
    Back, Ayoung
    Son, Minky
    Suh, Jung-Keun
    Kim, Hyong-Ha
    Lee, Keun Woo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (01) : 201 - 207
  • [32] Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease
    Lovett-Racke, AE
    Hussain, RZ
    Northrop, S
    Choy, J
    Rocchini, A
    Matthes, L
    Chavis, JA
    Diab, A
    Drew, PD
    Racke, MK
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5790 - 5798
  • [33] Two homoisoflavonoids act as peroxisome proliferator-activated receptor agonists
    Hsiang-Ru Lin
    Medicinal Chemistry Research, 2015, 24 : 2898 - 2905
  • [34] Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes
    Nicholls, Stephen J.
    Uno, Kiyoko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 89 - 94
  • [35] Molecular mechanisms and therapeutic perspectives of peroxisome proliferator-activated receptor α agonists in cardiovascular health and disease
    Pu, Yujie
    Cheng, Chak Kwong
    Zhang, Hongsong
    Luo, Jiang-Yun
    Wang, Li
    Tomlinson, Brian
    Huang, Yu
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (06) : 2086 - 2114
  • [36] Effects of peroxisome proliferator-activated receptor agonists on murine nonalcoholic liver injury.
    Fujii, K
    Nishitani, Y
    Matsumoto, H
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 10A - 10A
  • [37] Effects of peroxisome proliferator-activated receptor- agonists on the generation of microparticles by monocytes/macrophages
    Neri, Tommaso
    Cordazzo, Cinzia
    Carmazzi, Yuri
    Petrini, Silvia
    Balia, Cristina
    Stefanelli, Fabio
    Amoruso, Angela
    Brunelleschi, Sandra
    Breschi, Maria Cristina
    Pedrinelli, Roberto
    Paggiaro, Pierluigi
    Celi, Alessandro
    CARDIOVASCULAR RESEARCH, 2012, 94 (03) : 537 - 544
  • [38] Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes
    Yanjiao Li
    Yachen Shen
    Min Li
    Dongming Su
    Weifeng Xu
    Xiubin Liang
    Rongshan Li
    Molecular and Cellular Biochemistry, 2015, 405 : 233 - 241
  • [39] Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys
    Wallace, JM
    Schwarz, M
    Coward, P
    Houze, J
    Sawyer, JK
    Kelley, KL
    Chai, A
    Rudel, LL
    JOURNAL OF LIPID RESEARCH, 2005, 46 (05) : 1009 - 1016
  • [40] Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes
    Li, Yanjiao
    Shen, Yachen
    Li, Min
    Su, Dongming
    Xu, Weifeng
    Liang, Xiubin
    Li, Rongshan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 405 (1-2) : 233 - 241
12345